{"id":"https://openalex.org/W7225196673","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0076","title":"76 Tumor targeting and biodistribution of MK-4464, a CEACAM5-targeted NK cell engager, using [ 89 Zr]MK-4464 PET in preclinical models and cancer patients","display_name":"76 Tumor targeting and biodistribution of MK-4464, a CEACAM5-targeted NK cell engager, using [ 89 Zr]MK-4464 PET in preclinical models and cancer patients","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225196673","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0076"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0076","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0076","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0076","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A83.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A83.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160391685","display_name":"Tapan Nayak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tapan Nayak","raw_affiliation_strings":["Merck, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck, West Point, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120963841","display_name":"Xiangjun Meng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiangjun Meng","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054158601","display_name":"Kerry A. Riffel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kerry A Riffel","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019927985","display_name":"Daniel J. Rubins","orcid":"https://orcid.org/0000-0002-1587-6190","observed_orcids":["https://orcid.org/0000-0002-1587-6190"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J Rubins","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087373628","display_name":"Liza T. Gantert","orcid":"https://orcid.org/0000-0002-5042-8932","observed_orcids":["https://orcid.org/0000-0002-5042-8932"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liza Gantert","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004839794","display_name":"Dani\u00eblle J. Vugts","orcid":"https://orcid.org/0000-0001-7068-8152","observed_orcids":["https://orcid.org/0000-0001-7068-8152"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Danielle Vugts","raw_affiliation_strings":["Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160212403","display_name":"Ben Zwezerijnen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Ben Zwezerijnen","raw_affiliation_strings":["Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160484257","display_name":"Marc Huisman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marc Huisman","raw_affiliation_strings":["Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019928738","display_name":"Mari\u00ebtte Labots","orcid":"https://orcid.org/0000-0002-7095-1771","observed_orcids":["https://orcid.org/0000-0002-7095-1771"]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Mariette Labots","raw_affiliation_strings":["Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003904683","display_name":"Marloes van Dongen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marloes van Dongen","raw_affiliation_strings":["Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024540647","display_name":"Wouter V. Vogel","orcid":"https://orcid.org/0000-0002-4992-8024","observed_orcids":["https://orcid.org/0000-0002-4992-8024"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Wouter Vogel","raw_affiliation_strings":["Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antoni van Leeuwenhoek Hospital, Amsterdam, Noord-Holland, Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024773776","display_name":"Amy M. Beebe","orcid":"https://orcid.org/0000-0002-8892-0607","observed_orcids":["https://orcid.org/0000-0002-8892-0607"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy Beebe","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046222233","display_name":"Konstantin Dobrenkov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Konstantin Dobrenkov","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160517657","display_name":"C Willemien Menke-vander Houven van Oordt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151833","display_name":"Amsterdam University Medical Centers","ror":"https://ror.org/05grdyy37","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"C Willemien Menke-vander Houven van Oordt","raw_affiliation_strings":["Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Noord-Holland, Netherlands","institution_ids":["https://openalex.org/I4210151833","https://openalex.org/I865915315"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A83","last_page":"A83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ceacam5","display_name":"CEACAM5","score":0.9700000286102295},{"id":"https://openalex.org/keywords/nk-cell-engagers","display_name":"NK cell engagers","score":0.8989999890327454},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.7419999837875366},{"id":"https://openalex.org/keywords/nkg2d","display_name":"NKG2D","score":0.7799999713897705},{"id":"https://openalex.org/keywords/fcgammariiia","display_name":"Fc\u03b3RIIIa","score":0.9739999771118164},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.8790000081062317},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9940000176429749},{"id":"https://openalex.org/keywords/radiation-dosimetry","display_name":"radiation dosimetry","score":0.8169999718666077},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.652999997138977},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":1.0},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/tumor-to-blood-ratio","display_name":"tumor-to-blood ratio","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.8062999844551086},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7401999831199646},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.6940000057220459},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.636900007724762},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.44119998812675476},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.30970001220703125},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.2888000011444092},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2777999937534332},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.2621999979019165},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.243599995970726}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0076","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0076","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0076","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A83.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:5d6975107e5848739b170212fe886e3c","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/5d6975107e5848739b170212fe886e3c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 14, Iss Suppl 2 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0076","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0076","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0076","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A83.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":false},"content_urls":{"pdf":"https://content.openalex.org/works/W7225196673.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409633144","https://openalex.org/W4399380814","https://openalex.org/W2521243632","https://openalex.org/W2947619927","https://openalex.org/W7225166531","https://openalex.org/W3094021121","https://openalex.org/W7222281924","https://openalex.org/W2992129217","https://openalex.org/W4242510208","https://openalex.org/W4389400479"],"abstract_inverted_index":{"Background":[0],"MK-4464":[1,49],"is":[2],"a":[3,97,104,258],"bispecific,":[4],"trifunctional":[5],"antibody":[6,145],"designed":[7],"to":[8,26,73],"target":[9,75,277],"CEACAM5-expressing":[10,255],"tumors":[11,131],"while":[12],"activating":[13],"natural":[14],"killer":[15],"(NK)":[16],"cells":[17,70],"via":[18],"NKG2D":[19],"and":[20,30,38,44,56,77,88,179,250,266,279],"CD16A":[21],"engagement,":[22],"with":[23,64,132,143,147,165,170,215,242,257],"the":[24,93,152,176,271],"potential":[25],"enhance":[27],"both":[28,263],"innate":[29],"adaptive":[31],"antitumor":[32],"immunity.":[33],"We":[34],"evaluated":[35,84],"its":[36],"biodistribution":[37,260],"tumor-targeting":[39],"properties":[40],"in":[41,54,81,129,151,160,254,262],"preclinical":[42,264],"models":[43,265],"cancer":[45],"patients":[46,102,164],"using":[47],"zirconium-89\u2013labeled":[48],"([":[50],"89Zr]MK-4464).Methods":[51],"Preclinical":[52],"studies":[53],"CEACAM5-positive":[55,130],"CEACAM5-negative":[57],"tumor\u2013bearing":[58],"hIL15":[59],"transgenic":[60],"NSG":[61],"mice":[62],"engrafted":[63],"CD34":[65],"+":[66],"human":[67],"hematopoietic":[68],"stem":[69],"were":[71],"conducted":[72],"evaluate":[74],"specificity":[76],"dose-dependent":[78,135],"saturation.":[79,136],"Studies":[80],"cynomolgus":[82,138],"monkeys":[83],"normal":[85,155,223],"tissue":[86,280],"distribution":[87,140,281],"estimated":[89],"radiation":[90,234],"dosimetry.":[91],"In":[92,120,137],"imaging":[94,116],"cohort":[95],"of":[96,107,134,175,273,282],"Phase":[98],"1":[99,195],"study":[100],"(NCT05514444),":[101],"received":[103],"single":[105],"dose":[106],"[89Zr]MK-4464":[108],"during":[109],"cycle":[110,194],"1,":[111],"followed":[112],"by":[113],"serial":[114],"PET":[115],"over":[117,181],"one":[118],"week.Results":[119],"tumor-bearing":[121],"mouse":[122],"models,":[123],"[":[124,246],"89Zr]MK-4464":[125,247],"demonstrated":[126],"selective":[127,249],"uptake":[128,149,157,200,207,226,253],"evidence":[133],"monkeys,":[139],"was":[141,158,227,240],"consistent":[142,241],"typical":[144],"pharmacokinetics,":[146],"highest":[148,228],"observed":[150],"liver":[153,225],"among":[154],"tissues.Tumor":[156],"detected":[159],"all":[161],"four":[162],"evaluable":[163],"pancreatic":[166],"or":[167],"colorectal":[168],"cancer,":[169],"signal":[171],"intensity":[172],"exceeding":[173],"that":[174],"blood":[177],"pool":[178],"increasing":[180],"time,":[182],"reaching":[183],"tumor-to-blood":[184],"ratios":[185],"greater":[186],"than":[187],"2":[188],"at":[189],"later":[190],"time":[191],"points.":[192],"By":[193],"day":[196],"8,":[197],"mean":[198],"tumor":[199,252],"(SUV":[201,208,229],"10.2":[202],"\u00b1":[203,210,231,237],"4.9)":[204],"exceeded":[205],"spleen":[206],"3.1":[209],"1.0),":[211],"supporting":[212],"CEACAM5-mediated":[213],"targeting":[214],"limited":[216],"contribution":[217],"from":[218],"NKG2D-mediated":[219],"lymphoid":[220],"binding.":[221],"Among":[222],"tissues,":[224],"7.1":[230],"1.9).":[232],"Estimated":[233],"dosimetry":[235],"(0.77":[236],"0.04":[238],"mSv/MBq)":[239],"other":[243],"[89Zr]-labeled":[244],"antibodies.Conclusions":[245],"demonstrates":[248],"sustained":[251],"cancers":[256],"favorable":[259],"profile":[261],"patients.":[267],"These":[268],"findings":[269],"highlight":[270],"utility":[272],"immuno-PET":[274],"for":[275],"evaluating":[276],"engagement":[278],"NK":[283],"cell\u2013engaging":[284],"therapies.":[285]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}